Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer

NCT00257348 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: Capecitabine
DRUG: Docetaxel

Sponsor

University of California, Irvine

Collaborators

[object Object]